Dr. Gendelman is the Larson Professor of Medicine and Infectious Diseases, Chairman of the Department of Pharmacology and Experimental Neuroscience at the University of Nebraska Medical Center. He is credited for making substantive contributions in the biology of mononuclear phagocytes and in describing how metabolic changes in the brain ultimately lead to neural cell damage. Immunotherapy strategies were developed as a result of these works. Dr. Gendelman received his M.D. from the Pennsylvania State University-Hershey Medical Center where he was the 1999 Distinguished Alumnus. He occupied senior faculty and research positions at the Johns Hopkins Medical Institutions, the National Institute of Allergy and Infectious Diseases, the Uniformed Services University, the Walter Reed Army Institute of Research, and the Henry Jackson Foundation before joining the University of Nebraska Medical Center in March of 1993. He has authored over 350 peer-reviewed publications, edited nine books and is the Editor-In-Chief of the Journal of Neuroimmune Pharmacology. He is the recipient of the Jacob Javits Neuroscience Research Award and is amongst a selective scientific group listed on highly cited.com as being among the top 0.5 percentile cited investigators in his field.